United to End Cancer

submitted by: mdanderson

There are those who stand together to make a difference in the fight against cancer — The University of Texas MD Anderson Cancer Center’s community of donors. From across the world and all walks of life, these diverse supporters are united in their generosity toward the Moon Shots Program, the most ambitious assault on cancer ever undertaken by a single institution.

For more information and to make a donation, visit: mdanderson.org/gifts

Leukemia (AML/MDS) Moon Shots update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/leukemia-aml-mds-moon-shots/id431848... . Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world’s largest practice for treating AML and MDS. Guillermo Garcia-Manero, M.D., professor in Leukemia at MD Anderson, discusses milestones made with this MD Anderson moon shots,...

Chronic Lymphocytic Leukemia CLL Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveres into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Michael Keating, M.D., professor in MD Anderson's Leukemia...

AML and MDS Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Guillermo Garcia-Manero, M.D., professor in MD Anderson's...

Beating cancer via video game

submitted by: mdanderson
Steven Gonzalez, a patient at MD Anderson Children's Cancer Hospital, sees video games as a healing power rather than simply entertainment. When he began leukemia treatment as a young teenager, he felt separated from his peers and the normalcy of life. For Gonzalez, video games provided him a link to the world he knew before. To help other young cancer patients not feel so isolated, he created a cancer-fighting video game. He also joined patient committees at MD Anderson Children's Cancer...

Three new drugs increase options for CML patients

submitted by: mdanderson

Jorge Cortes, M.D., discusses how ponatinib, bosutinib and omacetaxine, approved by the FDA recently, can help chronic myeloid leukemia patients.

Facts about myelodysplastic syndrome

submitted by: mdanderson
Around 15,000 people in the United States are diagnosed each year with myelodysplastic syndrome (MDS). MDS occurs when the bone marrow does not properly produce one or more of the following: red blood cells, white blood cells and/or platelets. In the past it was thought MDS was only deadly when it developed into acute myelogenous leukemia (AML), but current research shows MDS can be fatal without reaching the stage of AML. Guillermo Garcia-Manero, M.D., professor in Leukemia, explains the...

Acute myeloid leukemia (AML) - a life threatening cancer

submitted by: mdanderson

Acute myeloid leukemia (AML) occurs when too many immature blood cells are produced by the bone marrow. Anemia, infection and bleeding may result and become life threatening. Guillermo Garcia-Manero, M.D., professor in Leukemia at MD Anderson Cancer Center, explains the symptoms, diagnosis and treatment of Acute myeloid leukemia.

Childhood Leukemia: Most Common Childhood Cancer

submitted by: mdanderson

Childhood leukemia is the most common childhood cancer with more than 3,500 children in the U.S. diagnosed each year. Patrick Zweidler-McKay, M.D., Ph.D., Assistant Professor at The University of Texas MD Anderson Cancer Center Children’s Cancer Hospital, talks about symptoms, diagnoses and treatment of this blood disease. Zweidler-McKay also discusses health problems that may occur decades after treatment and encourages long term follow-up doctor visits.

Treating Leukemia - Dr. Stefan Faderl

submitted by: mdanderson

Dr. Stefan Faderl discusses the basics of leukemia, his philosophy on treating the disease and MD Anderson's multicultural approach to care. He recognizes that leukemia patients require quick intervention and treatment. Learn more about Leukemia treatment at MD Anderson cancer center http://bit.ly/kHCp1G